NewAmsterdam Pharma (NAMS) Market Capitalization (2021 - 2026)
NewAmsterdam Pharma's Market Capitalization came in at $3.99 billion for Q2 2026, up 95.7% from $2.04 billion a year earlier and up 6.8% from the prior quarter.
Powered by 
Analysis
NewAmsterdam Pharma (NAMS) Market Capitalization (2021 - 2026) Analysis & Trends
For FY2025, NewAmsterdam Pharma's Market Capitalization was $4.01 billion, up 44.5% from FY2024.
- Market Capitalization has increased in each of the last four years, with a four-year compound annual growth rate of 103.2% (FY2021 to FY2025).
- Going back by year, Market Capitalization was $2.78 billion in FY2024 (+201.5%), $921.19 million in FY2023 (+3.6%), $889 million in FY2022 (+277.8%) and $235.28 million in FY2021.
- The five-year range for quarterly Market Capitalization is $235.28 million (Q4 2021) to $4.01 billion (Q4 2025).
- Year-over-year, Market Capitalization has increased for 11 consecutive quarters, with growth averaging 80.2% over the last eight quarters.
- Over the past five years, the year-over-year growth in Market Capitalization ranged from 3.6% (Q4 2023) to 277.8% (Q4 2022).
- Business Quant data shows NAMS's Market Capitalization at $3.73 billion (Q1 2026), $4.01 billion (Q4 2025) and $3.22 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | NewAmsterdam Pharma | 2.86 Bn | 2.86 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.99 Bn |
| Mar 31, 2026 | 3.73 Bn |
| Dec 31, 2025 | 4.01 Bn |
| Sep 30, 2025 | 3.22 Bn |
| Jun 30, 2025 | 2.04 Bn |
| Mar 31, 2025 | 2.30 Bn |
| Dec 31, 2024 | 2.78 Bn |
| Sep 30, 2024 | 1.53 Bn |
| Jun 30, 2024 | 1.73 Bn |
| Mar 31, 2024 | 2.12 Bn |
| Dec 31, 2023 | 921.19 Mn |
| Sep 30, 2023 | 762.85 Mn |
| Jun 30, 2023 | 978.84 Mn |
| Mar 31, 2023 | 1.08 Bn |
| Dec 31, 2022 | 889.00 Mn |
| Dec 31, 2021 | 235.28 Mn |
API Access
NewAmsterdam Pharma Market Capitalization API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=market-capitalization&ticker=NAMS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "market-capitalization", "ticker": "NAMS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=market-capitalization&ticker=NAMS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();